Ben Deng, chief investment officer of China Pacific Insurance Group, the third largest life and P&C insurer in China, tells David Walker how the Chinese market is coping with COVID-19 disruptions, and how China will come out of it stronger.
As happened in the other recent crises central banks stepped into markets impacted by COVID-19. But did they do enough, and were they fast enough? Insurance Asset Risk gauges insurance stakeholders' opinions. Vincent Huck reports
The pandemic and its effect on the economy and markets will not affect allocation trends towards emerging markets and in particular increased interest in Chinese opportunities. Invesco head of EMEA for fixed income Nick Tolchard discusses the reasons why China remains a land of opportunities. Interview by Stephanie Harris
Elizabeth Gillam, head of EU government relations and public policy at Invesco, discusses the European Union re-prioritisation of work streams in light of the COVID-19 crisis, and why sustainability will come out on top. Interview by Vincent Huck
Elisabeth Stadler, chief executive of Vienna Insurance Group, has been one of the industry's most long-standing advocates of social investing - the "S" in ESG. As combating COVID-19 heightens the general awareness of socially-minded investing, she discusses the topic with David Walker
Stuart Jarvis looks at how reporting rules have developed and why they are tightening, and how insurers can approach investment decisions in the new ALM landscape.
Investment markets look for brighter days even while the gloomiest persist. Some insurers' chief investment officers are doing the same, as David Walker reports
As some insurers follow suit on regulators' urge not to pay dividends and others refuse to comply, Vincent Huck looks at whether dividend retention could result in more ammunition for the investment teams to invest in markets
Frank Schiller, board member of the DAV, tells David Walker in a far ranging interview his thoughts on the 2020 Solvency II review and where he believes EIOPA needs to step up its work.
As European regulators offer some leeway on Solvency II regulatory reporting deadlines, insurers seem inclined to follow the original schedule. Begging the question of how to account for the COVID-19 impact. David Walker reports